Quarterly ResultJun 22, 2026, 09:03 AM
INVO Fertility Q1 Revenue Up 23% to $2.0M; Eliminates Preferred Stock
AI Summary
INVO Fertility, Inc. reported a 23% increase in revenue to $2,015,225 for the first quarter ended March 31, 2026, driven by organic growth and the acquisition of Family Beginnings. The company significantly strengthened its balance sheet by eliminating all Series C-2 Preferred Stock and warrant liabilities, leading to a 108% increase in stockholders' equity to $15.0 million and a 26% reduction in total liabilities. Despite these improvements, the net loss from continuing operations widened to $(5.5) million, primarily due to a non-cash loss on warrant fair value changes, and Adjusted EBITDA was $(1.26) million, attributed to investments in operational infrastructure for future expansion.
Key Highlights
- Revenue increased 23% to $2,015,225 for Q1 2026 compared to Q1 2025.
- All Series C-2 Preferred Stock and warrant liabilities were eliminated as of March 31, 2026.
- Stockholders' equity increased 108% to $15.0 million at March 31, 2026.
- Cash increased to $4.9 million at March 31, 2026, from $2.1 million at December 31, 2025.
- Total liabilities decreased 26% to $9.6 million at March 31, 2026.
- Net loss from continuing operations was $(5.5) million, including a $3.8 million non-cash loss.
- Adjusted EBITDA was $(1.26) million, reflecting investments for future growth.
- Acquired Family Beginnings P.C. in February 2026, expanding its Midwest presence.
Price Impact
More from IVF